BG64369B1 - Използване на плевромутилинови производни във ветеринарната практика - Google Patents

Използване на плевромутилинови производни във ветеринарната практика Download PDF

Info

Publication number
BG64369B1
BG64369B1 BG103002A BG10300298A BG64369B1 BG 64369 B1 BG64369 B1 BG 64369B1 BG 103002 A BG103002 A BG 103002A BG 10300298 A BG10300298 A BG 10300298A BG 64369 B1 BG64369 B1 BG 64369B1
Authority
BG
Bulgaria
Prior art keywords
compound
formula
veterinary
free base
treatment
Prior art date
Application number
BG103002A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG103002A (en
Inventor
David Burch
Paul Ripley
Erich Zeisl
Original Assignee
Biochemie Gesellschaft M.B.H.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614013.2A external-priority patent/GB9614013D0/en
Priority claimed from GBGB9614016.5A external-priority patent/GB9614016D0/en
Priority claimed from GBGB9614014.0A external-priority patent/GB9614014D0/en
Priority claimed from GBGB9614018.1A external-priority patent/GB9614018D0/en
Priority claimed from GBGB9614019.9A external-priority patent/GB9614019D0/en
Priority claimed from GBGB9614015.7A external-priority patent/GB9614015D0/en
Priority claimed from GBGB9614012.4A external-priority patent/GB9614012D0/en
Application filed by Biochemie Gesellschaft M.B.H. filed Critical Biochemie Gesellschaft M.B.H.
Publication of BG103002A publication Critical patent/BG103002A/xx
Publication of BG64369B1 publication Critical patent/BG64369B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BG103002A 1996-07-04 1998-12-08 Използване на плевромутилинови производни във ветеринарната практика BG64369B1 (bg)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GBGB9614013.2A GB9614013D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614016.5A GB9614016D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614017.3A GB9614017D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614014.0A GB9614014D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614018.1A GB9614018D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614019.9A GB9614019D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614015.7A GB9614015D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614012.4A GB9614012D0 (en) 1996-07-04 1996-07-04 Organic compounds

Publications (2)

Publication Number Publication Date
BG103002A BG103002A (en) 1999-09-30
BG64369B1 true BG64369B1 (bg) 2004-12-30

Family

ID=27571326

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103002A BG64369B1 (bg) 1996-07-04 1998-12-08 Използване на плевромутилинови производни във ветеринарната практика

Country Status (25)

Country Link
US (1) US6130250A (de)
EP (4) EP1808171A1 (de)
JP (1) JP4165769B2 (de)
CN (1) CN1121216C (de)
AT (2) ATE503475T1 (de)
AU (1) AU718701B2 (de)
BG (1) BG64369B1 (de)
BR (1) BR9710208A (de)
CA (1) CA2256514C (de)
CZ (4) CZ298444B6 (de)
DE (1) DE69740162D1 (de)
DK (2) DK0910363T3 (de)
ES (2) ES2364414T3 (de)
GB (1) GB9614017D0 (de)
HU (1) HU230325B1 (de)
IL (1) IL127299A (de)
NO (1) NO326117B1 (de)
NZ (1) NZ333261A (de)
OA (1) OA10951A (de)
PL (1) PL189204B1 (de)
PT (2) PT1813272E (de)
RU (1) RU2197237C2 (de)
SK (4) SK285857B6 (de)
UA (1) UA56173C2 (de)
WO (1) WO1998001127A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI260220B (en) * 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
TWI228048B (en) * 1999-12-09 2005-02-21 Novartis Ag New formulation
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
US6682762B2 (en) * 2001-10-09 2004-01-27 Heart-O-Dixie Animal Nutrition, Llc Poultry and livestock feed additive
CO5390081A1 (es) 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
EP1686115A1 (de) * 2005-01-26 2006-08-02 Novartis AG Organische Säureadditionssalze von Valnemulin
DE102006021493B4 (de) * 2006-05-09 2010-04-01 Bruker Daltonik Gmbh Massenspektrometrische Messung mikrobieller Resistenzen
EP2014645A1 (de) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin-derivate und ihre Verwendung als antimikrobielles Wirkungsmittel
CN101690717B (zh) * 2009-09-30 2013-03-06 北京大北农动物保健科技有限责任公司 一种兽用沃尼妙林及其盐的预混剂及制备方法
CN102415989A (zh) * 2011-09-30 2012-04-18 上海恒丰强动物药业有限公司 盐酸沃尼妙林溶液剂及其制备方法
CN103520099A (zh) * 2013-10-30 2014-01-22 王玉万 含有效成份为沃尼妙林的长效注射剂

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153277A2 (de) * 1984-02-17 1985-08-28 Sandoz Ag Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130709A (en) * 1977-12-08 1978-12-19 Eli Lilly And Company Pleuromutilin glycoside derivatives
US4247542A (en) * 1978-06-22 1981-01-27 Eli Lilly And Company A-40104 Antibiotics and process for production thereof
DE3405632A1 (de) * 1984-02-17 1985-08-22 Sandoz-Patent-GmbH, 7850 Lörrach Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
AT392272B (de) * 1989-10-03 1991-02-25 Biochemie Gmbh Verfahren zur herstellung eines pleuromutilinderivats und seiner saeureadditionssalze
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
CN1039585C (zh) * 1993-01-01 1998-08-26 生化企业 截短侧耳素衍生物与环糊精的配合物和含有它的药物制剂

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153277A2 (de) * 1984-02-17 1985-08-28 Sandoz Ag Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US4675330A (en) * 1984-02-17 1987-06-23 Sandoz Ltd. Pleuromutilin derivatives process for their preparation and their use

Also Published As

Publication number Publication date
JP4165769B2 (ja) 2008-10-15
UA56173C2 (uk) 2003-05-15
IL127299A (en) 2005-05-17
EP0910363A1 (de) 1999-04-28
CZ438198A3 (cs) 1999-03-17
CN1121216C (zh) 2003-09-17
SK286431B6 (sk) 2008-10-07
CA2256514C (en) 2006-11-28
SK2799A3 (en) 1999-09-10
DK1813272T3 (da) 2011-07-18
CA2256514A1 (en) 1998-01-15
SK285711B6 (sk) 2007-06-07
ES2360813T3 (es) 2011-06-09
CN1223576A (zh) 1999-07-21
HU230325B1 (hu) 2016-02-29
EP1810672A1 (de) 2007-07-25
PT1813272E (pt) 2011-04-29
ATE509625T1 (de) 2011-06-15
AU3692997A (en) 1998-02-02
RU2197237C2 (ru) 2003-01-27
US6130250A (en) 2000-10-10
PL330726A1 (en) 1999-05-24
SK286445B6 (sk) 2008-10-07
EP1813272A1 (de) 2007-08-01
DK0910363T3 (da) 2011-09-05
PT910363E (pt) 2011-05-31
EP0910363B1 (de) 2011-05-18
WO1998001127A1 (en) 1998-01-15
CZ298444B6 (cs) 2007-10-03
NO986198L (no) 1998-12-30
CZ298385B6 (cs) 2007-09-19
NZ333261A (en) 2000-09-29
BR9710208A (pt) 1999-08-10
HUP9903103A2 (hu) 2000-02-28
PL189204B1 (pl) 2005-07-29
CZ298446B6 (cs) 2007-10-03
IL127299A0 (en) 1999-09-22
BG103002A (en) 1999-09-30
GB9614017D0 (en) 1996-09-04
SK285857B6 (sk) 2007-09-06
AU718701B2 (en) 2000-04-20
NO326117B1 (no) 2008-09-29
ES2364414T3 (es) 2011-09-01
CZ298445B6 (cs) 2007-10-03
NO986198D0 (no) 1998-12-30
JP2000514072A (ja) 2000-10-24
DE69740162D1 (de) 2011-05-12
HUP9903103A3 (en) 2000-04-28
EP1813272B1 (de) 2011-03-30
ATE503475T1 (de) 2011-04-15
OA10951A (en) 2003-02-26
EP1808171A1 (de) 2007-07-18

Similar Documents

Publication Publication Date Title
Gharib et al. Comparison of the effects of probiotic, organic acid and medicinal plant on Campylobacter jejuni challenged broiler chickens
US20100311832A1 (en) Lactylates for the prevention and treatment of infections caused by gram positive bacteria in animals
HU198840B (en) Process for producing premixes with antibacterial effect, mixable into the drinking water of poultry
BG64369B1 (bg) Използване на плевромутилинови производни във ветеринарната практика
JPS5973527A (ja) 新規な動物の成長促進剤
US20240122953A1 (en) Methods for reducing pathogenic e coli by selective feed additive intervention
CN108992437B (zh) 月桂酰精氨酸乙酯作为兽用抗菌剂的用途
KR100516418B1 (ko) 플루로뮤틸린유도체의수의학적용도
TW410221B (en) A pharmaceutical composition for the use in the therapy of a veterinary disease complex caused by increasing stocking density
KR102430080B1 (ko) 메틸 갈레이트 및 틸로신을 포함하는 항균용 조성물
KR102208837B1 (ko) 메틸 갈레이트 및 플로로퀴놀론 계열 항균제를 포함하는 박테리아의 장 부착, 침입 억제, 또는 항생제 내성 억제용 조성물
KR102199186B1 (ko) 병원성 세균에 의한 질병의 예방 및 치료용 수의학적 조성물
MXPA99000264A (en) Veterinary use of a pleuromutil derivative
JPH0141609B2 (de)
Lannek et al. Therapeutical experiments with a new nitrofuran compound (Tiafur) in Salmonellosis of chicks
Palacios-Arriaga et al. Efficacy of florfenicol premix in weaning pigs experimentally infected with Actinobacillus pleuropneumoniae.
Jackson Effects of antibiotic regimens on bacterial resistance
NO331772B1 (no) Veterinaermedisinsk anvendelse av et pleuromutilinderivat
SI9200167A1 (en) Veterinary preparation containing an antibiotic mixture of gentamycin and lincomycin as an additive to drinking water or animal feed and its use in pig breeding
GB2183645A (en) Tiamulin pamoate